LBC Tank Terminals Holding Netherlands B.V. Announces Q2 FY20 Financial Results Conference Call
LBC Tank Terminals announced today it will hold a conference call to discuss its financial results for Q2 FY20 which ended on 31 December 2020.
The results will be published today, Tuesday 25th February 2020, followed by a conference call for all investors on Tuesday, 3rd March 2020 at 16:00 (Central European Time) / 10:00 (Eastern Standard Time).
Call details and copies of the financial statements will be made available on the Intralinks website.
Investors of LBC Tank Terminals Holding Netherlands B.V. Senior Notes, due 2023, can request access to Intralinks by contacting email@example.com .
LBC Tank Terminals
LBC Tank Terminals, with its headquarter in Belgium, is an independent operator of midstream and downstream bulk liquid storage facilities for chemicals, oils and refined petroleum products currently owning and operating seven terminals located in Houston, Freeport, Baton Rouge, Antwerp and Rotterdam with combined storage capacity of 2.5 million m³ serving over 100 customers including all major players. Our goal is simple: we aim to provide our customers with the safest, most reliable and efficient tank storage and logistical solutions. More information is available at www.lbctt.com
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NOVAREMED-AG25.5.2020 18:32:11 CEST | Press release
Novaremed Announces IND Submitted to U.S. FDA for Phase 2 Study of NRD135S.E1 for the Treatment of Painful Diabetic Peripheral Neuropathy; Also Announces the Appointment of Three New Board Members
EURID25.5.2020 13:32:05 CEST | Press release
Closer Collaboration between the EUIPO and EURid to Benefit SMEs
TIP-TRAILER-SERVICES25.5.2020 10:07:11 CEST | Press release
TIP Trailer Services Announces Appointment of New CFO
TEVA-PHARMACEUTICAL25.5.2020 08:02:15 CEST | Press release
Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab) Experience in Populations with Difficult-to-Treat Migraine
JEOL25.5.2020 08:02:15 CEST | Press release
JEOL: Release of a New Schottky Field Emission Scanning Electron Microscope JSM-IT800
IPSEN23.5.2020 07:02:12 CEST | Press release
Ipsen: New Surveys Show Over 80% of Patients with Spasticity and Cervical Dystonia Treated with Botulinum Toxin-A Experience Debilitating Symptom Recurrence
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom